See more : The Grob Tea Company Limited (GROBTEA.NS) Income Statement Analysis – Financial Results
Complete financial analysis of OMID Holdings, Inc. (OMID) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of OMID Holdings, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- PF Group Holdings Limited (8221.HK) Income Statement Analysis – Financial Results
- Passus S.A. (PAS.WA) Income Statement Analysis – Financial Results
- Tess Holdings Co.,Ltd. (5074.T) Income Statement Analysis – Financial Results
- Respiri Limited (RSH.AX) Income Statement Analysis – Financial Results
- Omnia Holdings Limited (OMN.JO) Income Statement Analysis – Financial Results
OMID Holdings, Inc. (OMID)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://omidholdingsinc.com
About OMID Holdings, Inc.
OMID Holdings, Inc., a health and wellness company, engages in the manufacture and sale of CBD-based products. The company is based in Phillipsburg, New Jersey.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 522.24K | 1.55M | 2.15M | 1.33M | 1.24K | 37.21K | 51.85K | 16.11K |
Cost of Revenue | 462.02K | 1.64M | 1.30M | 692.46K | 0.00 | 0.00 | 41.96K | 14.67K |
Gross Profit | 60.21K | -87.82K | 853.70K | 637.61K | 1.24K | 37.21K | 9.89K | 1.44K |
Gross Profit Ratio | 11.53% | -5.66% | 39.72% | 47.94% | 100.00% | 100.00% | 19.08% | 8.95% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 346.55K | 391.64K | 335.95K | 251.31K | 362.16K | 46.64K | 81.02K | 195.82K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 346.55K | 391.64K | 335.95K | 251.31K | 362.16K | 46.64K | 81.02K | 195.82K |
Cost & Expenses | 808.57K | 2.03M | 1.63M | 943.77K | 362.16K | 46.64K | 122.98K | 210.49K |
Interest Income | 295.93K | 81.52K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.50K | 24.67K |
Depreciation & Amortization | 22.05K | 24.53K | 23.80K | 11.83K | 171.86K | 161.14K | 52.52K | 22.82K |
EBITDA | 57.40K | -444.86K | 559.95K | 437.58K | -360.92K | -9.44K | -71.13K | -508.22K |
EBITDA Ratio | 10.99% | -29.31% | 25.20% | 29.93% | -29,106.45% | -25.37% | -137.18% | -1,206.50% |
Operating Income | -286.34K | -479.46K | 517.75K | 386.30K | -360.92K | -9.44K | -71.13K | -194.38K |
Operating Income Ratio | -54.83% | -30.89% | 24.09% | 29.04% | -29,106.45% | -25.37% | -137.18% | -1,206.50% |
Total Other Income/Expenses | 321.69K | 10.07K | 21.39K | 39.46K | 0.00 | 0.00 | -2.50K | -338.50K |
Income Before Tax | 35.36K | -469.39K | 539.14K | 425.76K | -360.92K | -9.44K | -73.63K | -532.88K |
Income Before Tax Ratio | 6.77% | -30.25% | 25.09% | 32.01% | -29,106.37% | -25.36% | -142.00% | -3,307.58% |
Income Tax Expense | 713.00 | -138.86K | 55.09K | 8.00 | -171.86K | -161.14K | -52.52K | -22.82K |
Net Income | 34.64K | -330.53K | 484.05K | 425.76K | -360.92K | -9.44K | -73.63K | -532.88K |
Net Income Ratio | 6.63% | -21.30% | 22.52% | 32.01% | -29,106.37% | -25.36% | -142.00% | -3,307.58% |
EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
Weighted Avg Shares Out | 96.35M | 96.35M | 174.84M | 237.94M | 79.20M | 72.68M | 72.68M | 101.20M |
Weighted Avg Shares Out (Dil) | 96.35M | 96.35M | 174.84M | 237.94M | 79.20M | 72.68M | 72.68M | 101.20M |
Cannabis Wellness Co. OMID Holdings Reports Record Revenue For Q4 & FY 2021
Source: https://incomestatements.info
Category: Stock Reports